The U.S. Department of Agriculture’s (USDA’s) Center for Veterinary Biologics (CVB) and Food Safety and Inspection Service (FSIS) have published a notice to inform veterinary biologics manufacturers of FSIS’ interest in Salmonella vaccines for poultry.
FSIS’ interest in vaccines stems from its proposed regulatory framework for Salmonella in raw poultry products, published in August 2024. The new regulatory framework aims to reduce human cases of salmonellosis attributable to poultry. The proposal would establish final product standards to prevent from entering into commerce raw chicken carcasses, chicken parts, comminuted chicken, and comminuted turkey products that contain any type of Salmonella at or above 10 colony forming units (CFU) per gram/milliliter, as well as any detectable level of at least one of the Salmonella serotypes of public health significance (Enteritidis, Typhimurium, and I,4,[5],12:I:- for chicken; and Hadar, Typhimurium, and Muenchen for turkey). FSIS is also seeking comment on S. Infantis on its possible inclusion as a serotype of public health significance. Read more